Welcome, Guest. Please login or register.
August 03, 2021, 02:09:20 pm

Login with username, password and session length


Members
  • Total Members: 6260
  • Latest: gr8inTx
Stats
  • Total Posts: 55050
  • Total Topics: 4835
  • Online Today: 56
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 41
Total: 41

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: HBsAg Quant Assay  (Read 4273 times)

0 Members and 1 Guest are viewing this topic.

Offline ArtVandelay

  • Member
  • Posts: 51
HBsAg Quant Assay
« on: August 04, 2015, 01:04:22 pm »
Through my reading about HBV and various treatments. It seems that several studies have suggested/found that having a lower surface antigen level to begin with increases the chance of seroconversion when treatment is given (particularly the treatment I am on (TDF with peg inf alfa 2a).

The current debate in the US is whether the Quant Assay for the surface antigen holds any merit. Right now you can only get the quantitative test overseas.

My personal opinion is that if the chance of clearing surface antigen goes up significantly if your level is low...and your chances are not good at all if your level is high - we should have access to the quant assay here to determine potential treatment options.

Thoughts?

 


© 2021 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.